日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pharmacokinetic-Pharmacodynamic Modelling in Hemophilia A: Relating Thrombin and Plasmin Generation to Factor VIII Activity After Administration of a VWF/FVIII Concentrate

A型血友病的药代动力学-药效学模型:VWF/FVIII浓缩物给药后凝血酶和纤溶酶生成与VIII因子活性的关系

Valke, Lars L F G; Cloesmeijer, Michael E; Mansouritorghabeh, Hassan; Barteling, Wideke; Blijlevens, Nicole M A; Cnossen, Marjon H; Mathôt, Ron A A; Schols, Saskia E M; van Heerde, Waander L

Combining factor VIII levels and thrombin/plasmin generation: A population pharmacokinetic-pharmacodynamic model for patients with haemophilia A

结合因子VIII水平和凝血酶/纤溶酶生成:血友病A患者的群体药代动力学-药效学模型

Bukkems, Laura H; Valke, Lars L F G; Barteling, Wideke; Laros-van Gorkom, Britta A P; Blijlevens, Nicole M A; Cnossen, Marjon H; van Heerde, Waander L; Schols, Saskia E M; Mathôt, Ron A A

Platelet CD34 expression in a patient with a partial deletion of transcription factor subunit CBFB

CBFB转录因子亚基部分缺失患者血小板CD34表达

van Bergen, Maaike G J M; Saes, Joline L; Simons, Annet; Hebeda, Konnie M; Henskens, Yvonne M C; Barteling, Wideke; Huys, Erik; Laros-van Gorkom, Britta A P; Schols, Saskia E M; Preijers, Frank W; Jongmans, Marjolijn C J; Jansen, Joop H; van der Reijden, Bert A

Pharmacodynamic monitoring of factor VIII replacement therapy in hemophilia A: Combining thrombin and plasmin generation

血友病A中VIII因子替代疗法的药效学监测:凝血酶和纤溶酶生成的联合应用

Valke, Lars L F G; Bukkems, Laura H; Barteling, Wideke; Laros-van Gorkom, Britta A P; Blijlevens, Nicole M A; Mathôt, Ron A A; van Heerde, Waander L; Schols, Saskia E M

Small peptides induce antibodies with a sequence and structural requirement for binding antigen comparable to antibodies raised against the native protein

小肽诱导产生的抗体,其序列和结构与针对天然蛋白产生的抗体在结合抗原方面具有相似的要求。

Geysen, H M; Barteling, S J; Meloen, R H